{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:36:09Z","timestamp":1792701369018,"version":"4.5.0"},"reference-count":36,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"DOI":"10.3892\/ijo.2019.4790","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T04:54:30Z","timestamp":1555476870000},"source":"Crossref","is-referenced-by-count":7,"title":["Toll\u2011like receptor 4 plays a tumor\u2011suppressive role in cutaneous squamous cell carcinoma"],"prefix":"10.3892","author":[{"given":"Erina","family":"Mikami","sequence":"first","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo 113\u20118603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo 113\u20118603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Nippon Medical School Musashikosugi Hospital, Kawasaki, Kanagawa\ufffd211\u20118533, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoko","family":"Kawahara","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo 113\u20118603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Kawamoto","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo 113\u20118603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Teduka","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo 113\u20118603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenori","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo 113\u20118603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeko","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo 113\u20118603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Kure","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo 113\u20118603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousuke","family":"Ishino","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo 113\u20118603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sakatani","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo 113\u20118603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo 113\u20118603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehisa","family":"Saeki","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nippon Medical School, Tokyo 113\u20118603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenya","family":"Naito","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo 113\u20118603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2019,4,17]]},"reference":[{"key":"key20200713185825_b1-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s40257-016-0207-3","article-title":"Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease","volume":"17","author":"Burton","year":"2016","journal-title":"Am J Clin Dermatol"},{"key":"key20200713185825_b2-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jaad.2012.11.037","article-title":"Cutaneous squamous cell carcinoma: Estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012","volume":"68","author":"Karia","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"key20200713185825_b3-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s00262-008-0650-y","article-title":"Toll-like receptor expression in normal ovary and ovarian tumors","volume":"58","author":"Zhou","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"key20200713185825_b4-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.yexcr.2016.07.009","article-title":"Toll-like receptor 4 promotes angiogenesis in pancreatic cancer via PI3K\/AKT signaling","volume":"347","author":"Sun","year":"2016","journal-title":"Exp Cell Res"},{"key":"key20200713185825_b5-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.molimm.2015.10.015","article-title":"Toll-like receptor 4 signaling promotes invasion of hepatocellular carcinoma cells through MKK4\/JNK pathway","volume":"68","author":"Dong","year":"2015","journal-title":"Mol Immunol"},{"key":"key20200713185825_b6-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.lfs.2016.05.012","article-title":"TLR4 siRNA inhibits proliferation and invasion in colorectal cancer cells by downregulating ACAT1 expression","volume":"155","author":"Ye","year":"2016","journal-title":"Life Sci"},{"key":"key20200713185825_b7-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"52032","DOI":"10.18632\/oncotarget.10496","article-title":"sTLR4\/MD-2 complex inhibits colorectal cancer in vitro and in vivo by targeting LPS","volume":"7","author":"Zou","year":"2016","journal-title":"Oncotarget"},{"key":"key20200713185825_b8-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00403-012-1300-y","article-title":"Expression of TLR3, 4, 7 and 9 in cutaneous malignant melanoma: Relationship with clinicopathological characteristics and prognosis","volume":"305","author":"Eir\u00f3","year":"2013","journal-title":"Arch Dermatol Res"},{"key":"key20200713185825_b9-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/php.12659","article-title":"Resatorvid-based Pharmacological Antagonism of Cutaneous TLR4 Blocks UV-induced NF-\u03baB and AP-1 Signaling in Keratinocytes and Mouse Skin","volume":"92","author":"Janda","year":"2016","journal-title":"Photochem Photobiol"},{"key":"key20200713185825_b10-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1158\/1940-6207.CAPR-17-0349","article-title":"Pharmacological TLR4 Antagonism Using Topical Resatorvid Blocks Solar UV-Induced Skin Tumorigenesis in SKH-1 Mice","volume":"11","author":"Blohm-Mangone","year":"2018","journal-title":"Cancer Prev Res (Phila)"},{"key":"key20200713185825_b11-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"e0185668","DOI":"10.1371\/journal.pone.0185668","article-title":"TLR4 as a negative regulator of keratinocyte proliferation","volume":"12","author":"Iotzova-Weiss","year":"2017","journal-title":"PLoS One"},{"key":"key20200713185825_b12-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4149\/gpb_2012_048","article-title":"Molecular biology of toll-like receptors","volume":"31","author":"Szatmary","year":"2012","journal-title":"Gen Physiol Biophys"},{"key":"key20200713185825_b13-ijo-54-06-2179","first-page":"1573","article-title":"Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: Its expression and effects in the ten most common cancers","volume":"6","author":"Mai","year":"2013","journal-title":"Onco Targets Ther"},{"key":"key20200713185825_b14-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.imbio.2016.06.009","article-title":"Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword","volume":"222","author":"Dajon","year":"2017","journal-title":"Immunobiology"},{"key":"key20200713185825_b15-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.yadr.2008.09.004","article-title":"Toll-like receptors in skin","volume":"24","author":"Miller","year":"2008","journal-title":"Adv Dermatol"},{"key":"key20200713185825_b16-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/1471-2407-13-311","article-title":"Expression and significance of HMGB1, TLR4 and NF-\u03baB p65 in human epidermal tumors","volume":"13","author":"Weng","year":"2013","journal-title":"BMC Cancer"},{"key":"key20200713185825_b17-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3389\/fimmu.2014.00135","article-title":"Toll-like receptors and skin cancer","volume":"5","author":"Burns","year":"2014","journal-title":"Front Immunol"},{"key":"key20200713185825_b18-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1158\/0008-5472.CAN-07-5219","article-title":"Protective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis","volume":"68","author":"Yusuf","year":"2008","journal-title":"Cancer Res"},{"key":"key20200713185825_b19-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1046\/j.1365-2133.2003.05028.x","article-title":"Hyaluronan, CD44 and versican in epidermal keratinocyte tumours","volume":"148","author":"Karvinen","year":"2003","journal-title":"Br J Dermatol"},{"key":"key20200713185825_b20-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/j.1365-2133.2009.09031.x","article-title":"Depletion of cell surface CD44 in nonmelanoma skin tumours is associated with increased expression of matrix metallopro-teinase 7","volume":"160","author":"Hartmann-Petersen","year":"2009","journal-title":"Br J Dermatol"},{"key":"key20200713185825_b21-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.5301\/jbm.5000165","article-title":"Comparative expression analysis of putative cancer stem cell markers CD44 and ALDH1A1 in various skin cancer subtypes","volume":"31","author":"Erfani","year":"2016","journal-title":"Int J Biol Markers"},{"key":"key20200713185825_b22-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fcell.2017.00018","article-title":"CD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer Cells","volume":"5","author":"Senbanjo","year":"2017","journal-title":"Front Cell Dev Biol"},{"key":"key20200713185825_b23-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/j.ajpath.2014.03.010","article-title":"Matrix hyaluronan-activated CD44 signaling promotes keratinocyte activities and improves abnormal epidermal functions","volume":"184","author":"Bourguignon","year":"2014","journal-title":"Am J Pathol"},{"key":"key20200713185825_b24-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/cm.20544","article-title":"Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NF\u03baB signaling leading to proinflammatory cytokine\/chemokine production and breast tumor invasion","volume":"68","author":"Bourguignon","year":"2011","journal-title":"Cytoskeleton (Hoboken)"},{"key":"key20200713185825_b25-ijo-54-06-2179","article-title":"WHO Classification of Skin Tumours Fourth Edition","volume-title":"WHO Classification of Tumours","author":"Elder","year":"2018"},{"key":"key20200713185825_b26-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1365-2133.1981.tb01196.x","article-title":"Establishment of a cell line of human skin squamous cell carcinoma in vitro","volume":"105","author":"Kondo","year":"1981","journal-title":"Br J Dermatol"},{"key":"key20200713185825_b27-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1346-8138.1990.tb01615.x","article-title":"Human squamous cell carcinoma from skin: Establishment and characterization of a new cell line (HSC-5)","volume":"17","author":"Hozumi","year":"1990","journal-title":"J Dermatol"},{"key":"key20200713185825_b28-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713185825_b29-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"210813","DOI":"10.1155\/2011\/210813","article-title":"Histopathological variants of cutaneous squamous cell carcinoma: A review","volume":"2011","author":"Yanofsky","year":"2011","journal-title":"J Skin Cancer"},{"key":"key20200713185825_b30-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PAP.0000000000000157","article-title":"Cutaneous Squamous Cell Carcinoma: Review of the Eighth Edition of the American Joint Committee on Cancer Staging Guidelines, Prognostic Factors, and Histopathologic Variants","volume":"24","author":"Motaparthi","year":"2017","journal-title":"Adv Anat Pathol"},{"key":"key20200713185825_b31-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ceb.2015.06.007","article-title":"Filopodia in cell adhesion, 3D migration and cancer cell invasion","volume":"36","author":"Jacquemet","year":"2015","journal-title":"Curr Opin Cell Biol"},{"key":"key20200713185825_b32-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"712561","DOI":"10.1155\/2013\/712561","article-title":"Stimulation of TLR4 by LMW-HA induces metastasis in human papillary thyroid carcinoma through CXCR7","volume":"2013","author":"Dang","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"key20200713185825_b33-ijo-54-06-2179","first-page":"144","article-title":"Dual character of Toll-like receptor signaling: Pro-tumorigenic effects and anti-tumor functions","volume":"1835","author":"Yu","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"key20200713185825_b34-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"E3216","DOI":"10.1073\/pnas.1420811112","article-title":"TLR4 has a TP53-dependent dual role in regulating breast cancer cell growth","volume":"112","author":"Haricharan","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713185825_b35-ijo-54-06-2179","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13045-018-0605-5","article-title":"The biology and role of CD44 in cancer progression: Therapeutic implications","volume":"11","author":"Chen","year":"2018","journal-title":"J Hematol Oncol"},{"key":"key20200713185825_b36-ijo-54-06-2179","volume-title":"TNM Classification of Malignant Tumours","author":"Brierley","year":"2016","edition":"8th edition"}],"container-title":["International Journal of Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:04:30Z","timestamp":1594667070000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijo.2019.4790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,17]]},"references-count":36,"URL":"https:\/\/doi.org\/10.3892\/ijo.2019.4790","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,17]]}}}